Eversept Partners’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-52,970
| Closed | -$13M | – | 75 |
|
2022
Q3 | $13M | Sell |
52,970
-16,327
| -24% | -$4.01M | 1.13% | 19 |
|
2022
Q2 | $17.2M | Buy |
+69,297
| New | +$17.2M | 1.22% | 21 |
|
2019
Q4 | – | Sell |
-29,950
| Closed | -$5.33M | – | 77 |
|
2019
Q3 | $5.33M | Buy |
+29,950
| New | +$5.33M | 1.65% | 16 |
|
2019
Q2 | – | Sell |
-27,339
| Closed | -$7.81M | – | 67 |
|
2019
Q1 | $7.81M | Buy |
27,339
+13,400
| +96% | +$3.83M | 2.28% | 13 |
|
2018
Q4 | $4.53M | Buy |
13,939
+10,520
| +308% | +$3.42M | 2.45% | 10 |
|
2018
Q3 | $1.54M | Sell |
3,419
-2,175
| -39% | -$978K | 0.67% | 28 |
|
2018
Q2 | $2.29M | Sell |
5,594
-1,500
| -21% | -$614K | 1.05% | 21 |
|
2018
Q1 | $2.06M | Sell |
7,094
-1,500
| -17% | -$436K | 0.96% | 23 |
|
2017
Q4 | $1.61M | Buy |
+8,594
| New | +$1.61M | 0.93% | 26 |
|